Initiative by Serendipity Partners, Pharm Assist and LINK Medical to establish North European Life Sciences Service Group (“LSSG”).

May 13, 2022 Uppsala, Sweden – Pharm Assist Sweden Holding AB announces today that 100% of the shares in Pharm Assist Sweden AB (“Pharm Assist”), have been acquired by a life science service group (“LSSG”), newly established by Serendipity Partners (“Serendipity”). Serendipity is a Norwegian investment company with NOK 2 billion under management, that invests in healthcare companies that provide benefits to patients and society.

LSSG was established to develop a North European life sciences service group with the mission to provide services to pharmaceutical, medical device and other life science companies to support the delivery of superior clinical outcomes, improved patient care, and market access.

As part of the strategy, LSSG recently announced the acquisition of the Norwegian CRO LINK Medical AS (“LINK Medical”). – “We are very happy to welcome Pharm Assist and its exceptional expert consultants as part of LSSG together with LINK Medical,” says Michael Bodd, Partner at Serendipity and Chairman of the Board in LSSG.

­­-­ “LSSG is a great home for Pharm Assist as we share the same company values and strategic vision as Serendipity and LINK Medical”, says Mats Ehrnebo, founder and owner of Pharm Assist. He continues, “Our clients will get personal links to our consultants through both a larger geographic footprint and service offering in the Nordics and northern Europe.” Dr. Ehrnebo will reinvest some of the proceeds from the sale into the new LSSG, and actively participate in the future development of the business.

­ ­- “Pharm Assist is complementary to LINK Medical both in terms of competence and service offering”, says Ola Gudmundsen, founder and CEO of LINK Medical. Dr. Gudmundsen continues, “We are looking forward to working together with Pharm Assist to support our clients with new services, faster delivery and better documentation of future medical treatments ”.

Initially, the new LSSG will employ above 250 people with annual revenues of approximately EUR 30 million. The two companies will operate as independent brands and drive synergies to increase value for clients.

About Pharm Assist

Pharm Assist is a consultancy company offering regulatory affairs services for pharmaceutical and medical device companies. Founded in 1996, Pharm Assist employs above 23 experts and has assisted more than 250 Nordic and international companies. Pharm Assist acts as partner in product development, authoring and compilation of dossiers for submission, quality assurance, regulatory procedures and maintenance, medical writing, pharmacovigilance and Good Distribution Practice. Through a network of qualified partners, Pharm Assist can provide support throughout the Nordic markets, in Europe and globally.

About Serendipity Partners

Serendipity Partners is the manager of two healthcare funds, which invest in healthcare companies that provide benefits to patients and society. The main healthcare segments that the fund invests in are pharmaceuticals, diagnostics, providers of healthcare services and medical technology. The fund has a Nordic focus and an established network of experienced leaders with experience from the healthcare sector. Serendipity Partners has NOK 2 billion under management.

About LINK Medical

LINK Medical is a full-service contract research organization (“CRO”) providing product development services for the pharmaceutical and medical device industries across Northern Europe. LINK Medical offers local presence in the Nordic region, Germany, and UK. Reaching from early phase development to post-marketing, the company has above 200 employees.

For more information:

Johan von Heijne, CEO Pharm Assist,

+46 705 95 15 10

Michael Bodd, Partner Serendipity Partners,

+47 986 70 250

Ola Gudmundsen, CEO Link Medical,

+47 924 62 200